Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2014; 20(7): 1657-1666
Published online Feb 21, 2014. doi: 10.3748/wjg.v20.i7.1657
Published online Feb 21, 2014. doi: 10.3748/wjg.v20.i7.1657
Figure 1 Cancer immunoediting phases.
A: Phase 1: Elimination. Tumor cells are recognized by innate and adaptive immune cell and are destroyed before they can become a clinical malignancy. Modified after Dunn GP[69]; B: Phase 2: Equilibrium. If tumor cells are not destroyed in the elimination phase, the tumor may enter an equilibrium phase. Genetic change and/or resistant to immune detection occur in the equilibrium phrase and tumor cells are maintained chronically. Modified after Dunn GP[69]; C: Phase 3: Escape. The tumor microenvironment allows that tumor cells to grow and change to become poorly immunogenic. The tumor microenvironment becomes immunosuppressive. Modified after Dunn GP[69]. NK: Natural killer; PD: Programmed death; IFN: Interferon; IL: Interleukin.
- Citation: Matsueda S, Graham DY. Immunotherapy in gastric cancer. World J Gastroenterol 2014; 20(7): 1657-1666
- URL: https://www.wjgnet.com/1007-9327/full/v20/i7/1657.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i7.1657